Showing results (1031-1040 of 3,790) with videos related to
Sort By:
Pageof 379
Oncoimmunology|July 29, 2016
Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsAlexander K Tsai, Eduardo DavilaOncoimmunology|July 29, 2016
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosisLucia Cottone, Annalisa Capobianco, Chiara Gualteroni, et al.Oncoimmunology|July 29, 2016
Cell-to-cell distances between tumor-infiltrating inflammatory cells have the potential to distinguish functionally active from suppressed inflammatory cellsS Nagl, M Haas, G Lahmer, et al.Oncoimmunology|July 29, 2016
Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinomaLin-Lin Bu, Guang-Tao Yu, Wei-Wei Deng, et al.Oncoimmunology|July 29, 2016
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLANadia Mensali, Fan Ying, Vincent Oei Yi Sheng, et al.Oncoimmunology|April 22, 2020
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance databaseQuentin Scanvion, Johana Béné, Sophie Gautier, et al.Oncoimmunology|April 22, 2020
Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patientsChao Wang, Tianyu Hong, Yuning Wang, et al.Oncoimmunology|April 22, 2020
Identification and characterization of M6903, an antagonistic anti-TIM-3 monoclonal antibodyDong Zhang, Feng Jiang, Rinat Zaynagetdinov, et al.Oncoimmunology|April 22, 2020
Liver metastases and the efficacy of the PD-1 or PD-L1 inhibitors in cancer: a meta-analysis of randomized controlled trialsShan Li, Shanquan Sun, Hui Xiang, et al.Oncoimmunology|April 22, 2020
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functionsKerri Wolf-Dennen, Nancy Gordon, Eugenie S KleinermanPageof 379